"Association between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?"

Prostaglandins & Other Lipid Mediators
Marilita M MoschosDimitris Brouzas

Abstract

To assess the role of plasma platelet activating factor acetylhydrolase (PAF-AH) in pathogenesis and progression of diabetic retinopathy (DR). Sixty eight diabetics and 23 age-frequency-matched non-diabetic patients underwent blood sampling and the plasma PAF-AH activity was calculated. The diabetic patients were further classified into two groups, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, based on indirect fundoscopy and fluorescein angiography. Thirty seven patients with non-proliferative DR (NPDR) and 31 patients with proliferative DR (PDR) were finally included in the study. The plasma PAF-AH activity was increased in diabetic patients with PDR (0.206 μmol/min/ml) compared to control group (0.114 μmol/min/ml, post-hoc Bonferroni comparison test: p<0.0001) and to NPDR group (0.147 μmol/min/ml, post-hoc Bonferroni comparison test: p=0.012). The activity of PAF-AH in the plasma increases in parallel with DR severity.

References

Mar 1, 1991·Archives of Ophthalmology·J T RosenbaumF H Valone
Apr 12, 1989·European Journal of Pharmacology·A ThierryG Meyniel
Jan 1, 1989·Experimental and Clinical Endocrinology·P SpangenbergU Till
Jul 18, 1997·The Journal of Biological Chemistry·D M StafforiniS M Prescott
Nov 4, 2000·Prostaglandins & Other Lipid Mediators·L TianoR Fiorini
Aug 25, 2004·Investigative Ophthalmology & Visual Science·Xiang MaNicolas G Bazan
Apr 27, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Pierre HardySylvain Chemtob
Aug 23, 2008·Prostaglandins & Other Lipid Mediators·Marilia de Brito GomesEduardo Tibiriçá
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Jan 25, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rebecca C GarlandAli Hafezi-Moghadam
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Jun 27, 2014·Mediators of Inflammation·Gabriel Olmos, Jerònia Lladó
Aug 1, 2014·Expert Opinion on Therapeutic Targets·Eirini NitodaMarilita M Moschos

❮ Previous
Next ❯

Citations

May 30, 2019·Medicinal Research Reviews·Fubao HuangJianhua Shen
Dec 29, 2020·Prostaglandins & Other Lipid Mediators·Barbara DalmasoCarolina Beltrame Del Debbio
Jun 19, 2021·Expert Opinion on Drug Discovery·Charikleia S BatsikaGeorge Kokotos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.